• Date
• Title

• 05/16/2012
• Catalent Announces Winners of Global Academic Competion

• 05/14/2012
• Drug Delivery/Formulation Issues Identified As Concerns In Technology Survey

• 05/11/2012
• Catalent Expert Gives Working Group Update At Conference

• 04/30/2012
• Biosimilars Webinar Presented by Catalent Expert

• 04/27/2012
• Case Study Presented on Achieving Biological Assay Success

• 04/17/2012
• Catalent Expert Presents at German Pharma Congress

• 04/16/2012
• Nascent and Catalent Sign Cancer Antibody Development Deal

• 04/12/2012
• Two Global Catalent Experts Present at AAPS Workshop

• 04/11/2012
• Catalent Expert To Share Formulation Development Expertise at Aerosol School

• 04/10/2012
• Catalent Expert to Present at ISPE Japan 2012

• 04/04/2012
• BASF and Catalent Join Forces to Solve Bioavailability Challenges

• 04/03/2012
• Catalent Expert Presents Case Study at PDA

• 03/30/2012
• Pharma Industry in NJ: A Panel Discussion

• 03/22/2012
• Catalent Extends Development and Analytical Solutions Capabilities in UK

• 03/15/2012
• Catalent Experts To Present Drug Delivery Technologies At ICSE/CPhI Japan 2012

• 03/12/2012
• Catalent Appoints a Vice President of Commercial Excellence

• 03/08/2012
• Expert Presents At The 5th Annual Comparator Studies Conference

• 03/07/2012
• Catalent Continues Investment In Global Clinical Supply Services

• 03/02/2012
• Drug Delivery Innovations Presented at 2nd Lyophilization Americas Conference

• 02/29/2012
• Catalent Acquires 100% of R.P. Scherer - Eberbach, Germany

• 02/21/2012
• Catalent Expert Presents on Protein Expression in CHO Cells

• 02/20/2012
• Catalent Expert Presents Effective Global Supply Chain Solutions

• 02/17/2012
• Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit

• 02/16/2012
• Catalent and NewMarket Pharmaceuticals to Develop Better Treatments

• 02/01/2012
• Expansion Advanced Dose Form Facility In Italy Complete

• 01/30/2012
• Catalent Acquires Current Minority Interest in R.P. Scherer, Eberbach, Germany

• 01/25/2012
• Catalent Expands Controlled Release Drug Development and Supply

• 01/19/2012
• Catalent Expert To Present On Virological Safety

• 01/18/2012
• Catalent Expert To Present On Technology Delivery

• 01/16/2012
• Catalent Expert to Present Strategies for Improved Oral Delivery